Angiosyn

company

About

Angiosyn, Inc. is a biopharmaceutical company developing novel proprietary biologics for controlling angiogenesis.

Details

Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2003
Operating Status
Active

Angiosyn, Inc. is a biopharmaceutical company developing novel proprietary biologics for controlling angiogenesis.

The company's initial therapeutic indication is for ophthalmic diseases, such as macular degeneration and diabetic retinopathy, which due to angiogenesis can lead to decreased vision and blindness